Click to view your profile
Click to search for condition or expert
Click to open main menu
Hemophagocytic Lymphohistiocytosis Latest Advances
Find the Latest Research About Hemophagocytic Lymphohistiocytosis
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/19/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications
See more filters
Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review.
Condition:
Panniculitis Associated Hemophagocytic Syndrome (HPS)
Journal:
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Treatment Used:
Ruxolitinib
Number of Patients:
2
Published:
December 19, 2022
VIEW PUBLICATION
A retrospective study of 18 children with subcutaneous panniculitis-like T-cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy?
Condition:
Children with Subcutaneous Panniculitis T-Cell Lymphoma (SPTCL)
Journal:
Orphanet journal of rare diseases
Treatment Used:
Multidrug Combination Chemotherapy vs. Immunomodulatory Therapy
Number of Patients:
18
Published:
December 12, 2022
VIEW PUBLICATION
Hemophagocytic lymphohistocytosis in trisomy 21: successful treatment with interferon inhibition.
Condition:
Trisomy 21/Hemophagocytic Lymphohistocytosis (HLH)
Journal:
Pediatric rheumatology online journal
Treatment Used:
Emapalumab Followed by Baricitinib
Number of Patients:
2
Published:
November 19, 2022
VIEW PUBLICATION
Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS.
Condition:
Secondary Hemophagocytic Lymphohistiocytosis (HLH) in Patients with AIDS
Journal:
Frontiers in immunology
Treatment Used:
Ruxolitinib
Number of Patients:
2
Published:
October 20, 2022
VIEW PUBLICATION
Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review.
Condition:
Extranodal Nature Killer/T-Cell Lymphoma (ENKTL) with Secondary Hemophagocytic Lymphohistiocytosis (HLH)
Journal:
Medicine
Treatment Used:
Sintilimab Combined with Chidamide
Number of Patients:
2
Published:
October 05, 2022
VIEW PUBLICATION
Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study.
Condition:
Secondary Hemophagocytic Lymph histiocytosis (sHLH)
Journal:
Orphanet journal of rare diseases
Treatment Used:
Tocilizumab
Number of Patients:
64
Published:
September 21, 2022
VIEW PUBLICATION
L-DEP regimen is effective as an initial therapy for adult EBV-HLH.
Condition:
Epstein-Barr Virus Driven Hemophagocytic Lymphohistiocytosis (EBV-HLH)
Journal:
Annals of hematology
Treatment Used:
PEG- Asparaginase Combined with Liposomal Doxorubicin, Etoposide, and Methylprednisolone (L-DEP)
Number of Patients:
47
Published:
September 12, 2022
VIEW PUBLICATION
Life-threatening hemophagocytic syndrome triggered by disseminated toxoplasmosis in a young patient with previously unknown AIDS.
Condition:
Hemophagocytic Syndrome with Disseminated Toxoplasmosis in Patient with AIDS
Journal:
La Revue de medecine interne
Treatment Used:
Etoposide, Anti-Toxoplasmosis Therapy, and Antiretroviral Therapy
Number of Patients:
1
Published:
September 11, 2022
VIEW PUBLICATION
Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Condition:
Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (EBV-HLH)
Journal:
Annals of hematology
Treatment Used:
Methotrexate Combined with Dexamethasone
Number of Patients:
57
Published:
September 07, 2022
VIEW PUBLICATION
Disseminated Toxoplasmosis associated with Haemophagocytic Lymphohistiocytosis in a Patient with the Human Immunodeficiency Virus: A Case Report and Literature Review.
Condition:
Disseminated Toxoplasmosis associated with Hemophagocytic Lymphohistiocytosis (DT-HLH) in Patient with Human Immunodeficiency Virus (HIV)
Journal:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Treatment Used:
Sulfamethoxazole-Trimethoprim, Trimethoprim, and Clindamycin
Number of Patients:
1
Published:
September 03, 2022
VIEW PUBLICATION
Ruxolitinib combined with liposomal doxorubicin, etoposide, methylprednisolone+/-PEG-asparaginase in treatment of relapsed/refractory pediatric hemophagocytic lymphohistiocytosis.
Condition:
Relapsed/Refractory Pediatric Hemophagocytic Lymphohistiocytosis (HLH)
Journal:
Zhonghua yi xue za zhi
Treatment Used:
Ruxolitinib Combined with Liposomal Doxorubicin, Etoposide, Methylprednisolone+/-PEG-Asparaginase (RU-DEP+/-L)
Number of Patients:
16
Published:
July 25, 2022
VIEW PUBLICATION
Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome.
Condition:
Lymphoma-Associated Hemophagocytic Syndrome (LAHS)
Journal:
Zhonghua yi xue za zhi
Treatment Used:
Anti-Lymphoma Treatment
Number of Patients:
94
Published:
July 25, 2022
VIEW PUBLICATION
Showing 1-12 of 146
Next
Last Updated: 02/19/2023